PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,787,207 | -10.4% | 268,776 | +23.8% | 0.00% | 0.0% |
| Q2 2023 | $3,110,103 | +104.6% | 217,186 | +2.0% | 0.00% | – |
| Q1 2023 | $1,520,114 | -35.8% | 212,901 | +0.9% | 0.00% | – |
| Q4 2022 | $2,367,970 | +11.5% | 211,049 | +10.1% | 0.00% | – |
| Q3 2022 | $2,124,000 | +32.6% | 191,709 | +1.0% | 0.00% | – |
| Q2 2022 | $1,602,000 | -34.2% | 189,888 | +6.2% | 0.00% | – |
| Q1 2022 | $2,433,000 | -34.2% | 178,810 | -4.8% | 0.00% | -100.0% |
| Q4 2021 | $3,696,000 | -38.1% | 187,905 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $5,973,000 | -9.4% | 186,076 | -4.5% | 0.00% | 0.0% |
| Q2 2021 | $6,596,000 | +33.2% | 194,876 | +47.8% | 0.00% | 0.0% |
| Q1 2021 | $4,952,000 | +13.5% | 131,856 | +0.4% | 0.00% | 0.0% |
| Q4 2020 | $4,363,000 | -10.2% | 131,321 | -0.9% | 0.00% | 0.0% |
| Q3 2020 | $4,857,000 | +2.9% | 132,448 | -7.7% | 0.00% | 0.0% |
| Q2 2020 | $4,721,000 | +39.3% | 143,453 | +9.3% | 0.00% | 0.0% |
| Q1 2020 | $3,389,000 | -4.9% | 131,258 | +14.7% | 0.00% | 0.0% |
| Q4 2019 | $3,563,000 | – | 114,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
| Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
| Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
| GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
| RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
| StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
| Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
| Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |